DRTS — Alpha Tau Medical Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 27.62 | ||
| Price to Tang. Book | 27.62 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -40.47% | ||
| Return on Equity | -141.68% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | 0.96 | 14.09 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alpha Tau Medical Ltd is an Israel-based medical technology company engaged in the research, development, and commercialization of innovative cancer treatment technologies. The Company focuses on Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), a platform designed for the treatment of solid tumors through the localized delivery of alpha radiation within tumor tissue. Its technology utilizes radioactive radium-224 sources that release short-range alpha particles intended to damage and destroy cancer cells while limiting exposure to surrounding healthy tissue. The Company conducts activities related to product development, clinical studies, regulatory approval processes, and commercialization. Alpha Tau Medical Ltd serves the oncology sector and carries out its operations directly and through its subsidiary, Healthcare Capital Corp.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- November 23rd, 2015
- Public Since
- March 8th, 2022
- No. of Shareholders
- 120
- No. of Employees
- 121
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 92,478,154
- Address
- Kiryat Hamada 5, Jerusalem, 9777605
- Web
- https://www.alphatau.com/
- Phone
- +972 null35774115
- Auditors
- Kost, Forer, Gabbay & Kasierer
Latest News for DRTS
Upcoming Events for DRTS
Alpha Tau Medical Ltd at Citi Oncology Leadership Summit
Similar to DRTS
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
Acurx Pharmaceuticals
NASDAQ Capital Market
FAQ
As of Today at 01:12 UTC, shares in Alpha Tau Medical are trading at $13.16. This share price information is delayed by 15 minutes.
Shares in Alpha Tau Medical last closed at $13.16 and the price had moved by +240.05% over the past 365 days. In terms of relative price strength the Alpha Tau Medical share price has outperformed the S&P500 Index by +191.09% over the past year.
The overall consensus recommendation for Alpha Tau Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAlpha Tau Medical does not currently pay a dividend.
Alpha Tau Medical does not currently pay a dividend.
Alpha Tau Medical does not currently pay a dividend.
To buy shares in Alpha Tau Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $13.16, shares in Alpha Tau Medical had a market capitalisation of $1.22bn.
Here are the trading details for Alpha Tau Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: DRTS
Based on an overall assessment of its quality, value and momentum Alpha Tau Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alpha Tau Medical is $17.80. That is 35.26% above the last closing price of $13.16.
Analysts covering Alpha Tau Medical currently have a consensus Earnings Per Share (EPS) forecast of -$0.96 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alpha Tau Medical. Over the past six months, its share price has outperformed the S&P500 Index by +50.45%.
As of the last closing price of $13.16, shares in Alpha Tau Medical were trading +28.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alpha Tau Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $13.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Alpha Tau Medical's directors